The translocator protein (TSPO): A novel target for cancer chemotherapy

被引：73
|
作者：
Austin, Christopher J. D. [1 ]
Kahlert, Jan [1 ]
Kassiou, Michael [1 ]
Rendina, Louis M. [1 ]
机构：
[1] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
来源：
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | 2013年 / 45卷 / 07期
关键词：
Translocator protein; TSPO; Cancer; Apoptosis; Cell homoeostasis; PERIPHERAL BENZODIAZEPINE-RECEPTOR; 18 KDA TSPO; MITOCHONDRIAL PERMEABILITY TRANSITION; DEPENDENT ANION CHANNELS; BINDING-SITES; COLONIC ADENOCARCINOMA; CHOLESTEROL TRANSPORT; DISEASE STATES; LIGANDS; TUMORS;
D O I：
10.1016/j.biocel.2013.03.004
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The translocator protein (TSPO) is an 18 kDa transmembrane protein primarily found in the outer mitochondrial membrane where it forms a key part of the mitochondrial permeability transition pore (MFTP). Omnipresent in almost all tissues, TSPO up-regulation has been connected to neuronal damage and inflammation, making the protein an important bio-imaging marker for disease progression. More recently, TSPO has attracted attention as a possible molecular target for tumour imaging and chemotherapy. In this review we summarize TSPO's molecular characteristics and highlight research progress in recent years in the field of TSPO-targeted cancer diagnostics and treatments. Crown Copyright (C) 2013 Published by Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码：1212 / 1216
页数：5
相关论文
共 50 条
  • [1] Translocator protein (TSPO) as an imaging target in pancreatic cancer
    McKinley, E. T.
    Tang, D.
    Merchant, N.
    Shi, C.
    Moses, H. L.
    Manning, H. C.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 : 17 - 17
  • [2] Translocator Protein (TSPO) in Breast Cancer
    Mukherjee, S.
    Das, S. K.
    CURRENT MOLECULAR MEDICINE, 2012, 12 (04) : 443 - 457
  • [3] Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain
    Liu, Jie
    Huang, Jingyao
    Zhang, Zhenjiang
    Zhang, Rui
    Zhang, Zhihao
    Liu, Yongxin
    Ma, Baoyu
    NEURAL PLASTICITY, 2022, 2022
  • [4] Translocator protein (18 kDa) TSPO: An emerging therapeutic target in neurotrauma
    Papadopoulos, Vassilios
    Lecanu, Laurent
    EXPERIMENTAL NEUROLOGY, 2009, 219 (01) : 53 - 57
  • [5] Translocator protein (TSPO) as a molecular imaging biomarker of pancreatic cancer
    McKinley, Eliot
    Tang, Dewei
    Powell, Anne
    Coffey, Robert
    Merchant, Nipun
    Shi, Chanjuan
    Moses, Harold
    Manning, H. Charles
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54
  • [6] Translocator protein (TSPO)-Targeted agents for photodynamic therapy of cancer
    Xie, Qing
    Su, Meng
    Liu, Yang
    Zhang, Dawei
    Li, Zhen
    Bai, Mingfeng
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 34
  • [7] Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders
    Rupprecht, Rainer
    Papadopoulos, Vassilios
    Rammes, Gerhard
    Baghai, Thomas C.
    Fan, Jinjiang
    Akula, Nagaraju
    Groyer, Ghislaine
    Adams, David
    Schumacher, Michael
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (12) : 971 - 988
  • [8] Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders
    Caroline Nothdurfter
    Thomas C. Baghai
    Cornelius Schüle
    Rainer Rupprecht
    European Archives of Psychiatry and Clinical Neuroscience, 2012, 262 : 107 - 112
  • [9] Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders
    Nothdurfter, Caroline
    Baghai, Thomas C.
    Schuele, Cornelius
    Rupprecht, Rainer
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2012, 262 : S107 - S112
  • [10] An Updated View of Translocator Protein (TSPO)
    Denora, Nunzio
    Natile, Giovanni
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
12345